Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Shira Peleg-Hasson"'
Autor:
Nadav Michaan, Moshe Leshno, Yoni Cohen, Tamar Safra, Shira Peleg-Hasson, Ido Laskov, Dan Grisaru
Publikováno v:
Reproductive Biology and Endocrinology, Vol 19, Iss 1, Pp 1-8 (2021)
Abstract Background Gynecologic oncologists should be aware of the option of conception through IVF/PGT-M for families with high BRCA related morbidity or mortality. Our objective was to investigate the cost-effectiveness of preimplantation genetic t
Externí odkaz:
https://doaj.org/article/30295400cb704a4b9b9b70749c882914
Autor:
Miriam R. Brezis, Eliya Shachar, Shira Peleg Hasson, Ido Laskov, Nadav Michaan, Bar Levy, Ido Wolf, Tamar Safra
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveTo evaluate the effectiveness and safety of standard chemotherapy administered to patients >70 years with advanced ovarian cancer (OC).MethodsMedical records of 956 advanced-stage patients with OC treated between 2002-2020 with standard surg
Externí odkaz:
https://doaj.org/article/fdc1c186302a4b198978a307a135f165
Autor:
Ido Laskov, Ayala Zilberman, Lihie Maltz-Yacobi, Shira Peleg Hasson, Aviad Cohen, Tamar Safra, Dan Grisaru, Nadav Michaan
Publikováno v:
International Journal of Gynecologic Cancer. 33:713-718
ObjectiveOur study aimed to explore the effect of body mass index (BMI) change on cancer recurrence risk during the routine surveillance of endometrial cancer patients.MethodsData on patients with endometrial adenocarcinoma that had a staging procedu
Autor:
Shira Peleg Hasson, Shira Felder, Limor Helpman, Alexandra Taylor, Michal Shalamov, Sireen Abuakar, Smadar Bauer, Ronnie Shapira-Frommer, Inbal Greenhouse, Jacob Korach, Tatiana Rabin, Jeffrey Goldstein, Akram Saad
Publikováno v:
International Journal of Gynecologic Cancer. 33:683-691
ObjectiveThe use of chemoradiation in patients with stage IVB cancer of the cervix was evaluated to determine if definitive treatment offers benefit.MethodsA database of 546 patients with cancer of the cervix treated between January 2005 and May 2021
Autor:
Eliya Shachar, Shira Peleg Hasson, Deborah T. Blumenthal, Meerav Fraenkel, Yoel Uri, Ido Wolf, Simona Grozinsky-Glasberg
Publikováno v:
Acta Oncologica. 61:819-823
Publikováno v:
JCO Oncology Practice. 17:e1559-e1566
PURPOSE: Traditionally, pathologists have been branded the doctor's doctor, with a position behind the microscope and limited interaction among patients, despite their rich understanding of disease development and ability to navigate personalized med
Autor:
Shira Peleg Hasson, Dov Hershkovitz, Lyri Adar, Miriam Brezis, Eliya Shachar, Rona Aks, Lee Galmor, Yuval Raviv, Shira Ben Neriah, Ofer Merimsky, Edmond Sabo, Ido Wolf, Tamar Safra
Publikováno v:
Cancers; Volume 15; Issue 1; Pages: 218
Comprehensive genomic profiling (CGP) allows for the detection of driver alterations at high resolution, but the limited number of approved targeted therapies and their high costs have contributed to its limited clinical utilization. We retrospective
Autor:
Miriam Brezis, Shira Peleg Hasson, Eliya Shachar, Dan Grisaro, Ido Laskov, Nadav Michaan, Lyri Adar, Avigail Harpaz, Adi Diner, Bar Levy, Ido Wolf, Tamar Safra
Publikováno v:
E-Posters.
Autor:
Miriam Rivka Brezis, Shira Peleg Hasson, Eliya Shachar, Dan Grisaro, Ido Laskov, Nadav Michaan, Lyri Adar, Avigail Harpaz, Adi Diner, Bar Levy, Ido Wolf, Tamar Safra
Publikováno v:
Ovarian cancer.
Autor:
Shira Peleg Hasson, Nicola Rosenfelder, Martin Brewer, Angela George, Liam Welsh, Susana Banerjee
Publikováno v:
Ovarian cancer.